• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Theralase Technologies Inc (OP:TLTFF)

    0.1410 +0.0090 (+6.82%)
    Streaming Delayed Price Updated: 3:35 PM EST, Jan 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 81,390
    Open 0.1389
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.1320
    Today's Range 0.1304 - 0.1535
    52wk Range 0.1019 - 0.2400
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Theralase(R) Closes $1.3 M Non-Brokered Private Placement
    Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
    Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile

    Performance

    YTD
    +6.8%
    +6.8%
    1 Month
    +24.1%
    +24.1%
    3 Month
    +0.5%
    +0.5%
    6 Month
    -7.4%
    -7.4%
    1 Year
    -34.9%
    -34.9%

    More News

    Read More
    News headline image
    Theralase(R) Investor Conference Call Reminder
    Via Newsfile
    News headline image
    Theralase(R) Releases 3Q2025 Financial Statements
    Via Newsfile
    News headline image
    Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
    Via Newsfile
    News headline image
    Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
    Via Newsfile
    Topics Derivatives
    News headline image
    Theralase(R) Extends Warrants
    Via Newsfile
    News headline image
    Theralase(R) Releases 2Q2025 Financial Statements
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Via Newsfile
    News headline image
    Theralase(R) Extends Warrants
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Via Newsfile
    News headline image
    Theralase Completes Annual General and Special Meeting
    Via Newsfile
    News headline image
    Theralase Annual General Meeting
    Via Newsfile
    News headline image
    Theralase(R) 1Q2025 Financial Statements
    Via Newsfile
    News headline image
    CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
    Via Newsfile
    News headline image
    Theralase to Present Groundbreaking Research at ASTRO 2025
    Via Newsfile
    News headline image
    Theralase Provides Corporate Update
    Via Newsfile
    News headline image
    Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
    Via Newsfile
    News headline image
    Theralase Discovers New Mechanism of Action of Lead Drug
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Via Newsfile
    News headline image
    Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
    Via Newsfile
    News headline image
    Ruvidar Demonstrates 7 Year Complete Response
    Via Newsfile
    News headline image
    Ruvidar Effective in the Treatment of Herpes
    Via Newsfile
    News headline image
    Theralase(R) Releases 2024 Annual Financial Statements
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Via Newsfile

    Frequently Asked Questions

    Is Theralase Technologies Inc publicly traded?
    Yes, Theralase Technologies Inc is publicly traded.
    What exchange does Theralase Technologies Inc trade on?
    Theralase Technologies Inc trades on the OTC Traded
    What is the ticker symbol for Theralase Technologies Inc?
    The ticker symbol for Theralase Technologies Inc is TLTFF on the OTC Traded
    What is the current price of Theralase Technologies Inc?
    The current price of Theralase Technologies Inc is 0.1410
    When was Theralase Technologies Inc last traded?
    The last trade of Theralase Technologies Inc was at 01/05/26 03:35 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.